Marex Group’s Avanos Medical AVNS Stock Holding History

Marex Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,800	Closed	-$361K	–	1142
2026 Q1	$361K	Hold	25,800	–	–	﹤0.01%	712
2025 Q4	$290K	Hold	25,800	–	–	﹤0.01%	715
2025 Q3	$298K	Buy	+25,800	New	+$302K	﹤0.01%	623

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Marex Group's AVNS Position: Q2 2026 in Review

Marex Group sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 25,800 shares — an estimated $361K sold.

Marex Group first reported a position in AVNS in Q3 2025 and held it in 3 quarters. The position peaked at $361K in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Marex Group reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
Marex Group sold 25,800 Avanos Medical shares in Q2 2026, an estimated $361K.
Marex Group first reported a position in Avanos Medical in Q3 2025 and held it in 3 quarters.
Marex Group's Avanos Medical position peaked at $361K in Q1 2026.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.